Chris Davis Viatris Inc Transaction History
Davis Selected Advisers
- $17.4 Billion
- Q3 2024
A detailed history of Chris Davis (Davis Selected Advisers) transactions in Viatris Inc stock. As of the latest transaction made, Davis Selected Advisers holds 62,647,266 shares of VTRS stock, worth $823 Million. This represents 4.18% of its overall portfolio holdings.
Number of Shares
62,647,266
Previous 57,535,953
8.88%
Holding current value
$823 Million
Previous $612 Million
18.92%
% of portfolio
4.18%
Previous 3.55%
Shares
16 transactions
Others Institutions Holding VTRS
# of Institutions
1,102Shares Held
934MCall Options Held
2.71MPut Options Held
2.4M-
Vanguard Group Inc Valley Forge, PA141MShares$1.85 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$1.22 Billion0.02% of portfolio
-
State Street Corp Boston, MA63.1MShares$829 Million0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD48.8MShares$641 Million0.07% of portfolio
-
Invesco Ltd. Atlanta, GA30.5MShares$401 Million0.07% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $15.9B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...